.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Mallinckrodt
Healthtrust
McKinsey
Federal Trade Commission
Merck
Queensland Health
Citi
Harvard Business School

Generated: July 24, 2017

DrugPatentWatch Database Preview

TRISENOX Drug Profile

« Back to Dashboard

Which patents cover Trisenox, and when can generic versions of Trisenox launch?

Trisenox is a drug marketed by Cephalon and is included in one NDA. There are six patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-two patent family members in eighteen countries.

The generic ingredient in TRISENOX is arsenic trioxide. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the arsenic trioxide profile page.

Summary for Tradename: TRISENOX

Patents:6
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list20
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRISENOX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cephalon
TRISENOX
arsenic trioxide
INJECTABLE;INJECTION021248-001Sep 25, 2000RXYesYes► Subscribe► Subscribe ► Subscribe
Cephalon
TRISENOX
arsenic trioxide
INJECTABLE;INJECTION021248-001Sep 25, 2000RXYesYes► Subscribe► Subscribe ► Subscribe
Cephalon
TRISENOX
arsenic trioxide
INJECTABLE;INJECTION021248-001Sep 25, 2000RXYesYes► Subscribe► Subscribe ► Subscribe
Cephalon
TRISENOX
arsenic trioxide
INJECTABLE;INJECTION021248-001Sep 25, 2000RXYesYes► Subscribe► Subscribe ► Subscribe
Cephalon
TRISENOX
arsenic trioxide
INJECTABLE;INJECTION021248-001Sep 25, 2000RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: TRISENOX

Drugname Dosage Strength RLD Submissiondate
arsenic trioxideInjection1 mg/mLTrisenox8/11/2015

Non-Orange Book Patents for Tradename: TRISENOX

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,770,304 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol► Subscribe
7,879,364Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: TRISENOX

Country Document Number Estimated Expiration
Indonesia25622► Subscribe
World Intellectual Property Organization (WIPO)9924029► Subscribe
Cyprus1113856► Subscribe
Canada2309652► Subscribe
Israel136051► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Moodys
Mallinckrodt
Cerilliant
Covington
Fish and Richardson
Colorcon
Dow
Chubb
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot